Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 215

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 215
---
 rely on GMP-certified contract manufacturers for our clinical trial material.

Environmental Matters and Seasonality

We may from time to time be
subject to various environmental, health and safety laws and regulations, including those governing air emissions, water and wastewater
discharges, noise emissions, the use, management and disposal of hazardous, radioactive and biological materials and wastes and the cleanup
of contaminated sites. We believe that our business, operations and facilities are being operated in compliance in all material respects
with applicable environmental and health and safety laws and regulations. Based on information currently available to us, we do not expect
environmental costs and contingencies to have a material adverse effect on it. The operation of our laboratory-scale manufacturing facility,
however, entails risks in these areas. Significant expenditures could be required in the future if these facilities are required to comply
with new or more stringent environmental or health and safety laws, regulations or requirements.

Our current business does
not generally reflect any significant degree of seasonality.

Legal Proceedings

From time to time, we may
be subject to various claims or legal proceedings that arise in the ordinary course of our business. Other than as disclosed in this annual
report, we currently are not a party to any legal proceedings, which, in the opinion of management, is likely to have or could reasonably
possibly have a material adverse effect on our business, financial condition or results of operations.

Property, Plant and Equipment

Our current headquarters is
located at 1 Caspian Point, Caspian Way, Cardiff, Wales, where we also have our laboratories and pilot scale manufacturing facility. We
entered into the lease for these premises in April 2021. The new premises comprise 754 square meters (approximately 8,118 square feet).
The lease expires in August 2026. We believe that this facility will be sufficient to meet our current needs.

Employees

The number of our employees
by geographic location and function as of the end of the period for the fiscal years ended December 31, 2023, 2022 and 2021 were as follows:

|                            |     | As of December 31, |    |     |      |    |     |      |    |
|                            |     |               2023 |    |     | 2022 |    |     | 2021 |    |
| Business functional area:  |     |                    |    |     |      |    |     |      |    |
| Research and development   |     |